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Background: Although care pathways are often said to promote teamwork, high-level evidence that supports this
statement is lacking. Furthermore, knowledge on conditions and facilitators for successful pathway implementation
is scarce. The objective of the European Quality of Care Pathway (EQCP) study is therefore to study the impact of
care pathways on interprofessional teamwork and to build up understanding on the implementation process.
Methods/design: An international post-test-only cluster Randomised Controlled Trial (cRCT), combined with
process evaluations, will be performed in Belgium, Ireland, Italy, and Portugal. Teams caring for proximal femur
fracture (PFF) patients and patients hospitalized with an exacerbation of chronic obstructive pulmonary disease
(COPD) will be randomised into an intervention and control group. The intervention group will implement a care
pathway for PFF or COPD containing three active components: a formative evaluation of the actual teams’
performance, a set of evidence-based key interventions, and a training in care pathway-development. The control
group will provide usual care. A set of team input, process and output indicators will be used as effect measures.
The main outcome indicator will be relational coordination. Next to these, process measures during and after
pathway development will be used to evaluate the implementation processes. In total, 132 teams have agreed to
participate, of which 68 were randomly assigned to the intervention group and 64 to the control group. Based
on power analysis, a sample of 475 team members per arm is required. To analyze results, multilevel analysis
will be performed.
Discussion: Results from our study will enhance understanding on the active components of care pathways.
Through this, preferred implementation strategies can be defined.
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Interprofessional teamwork is essential for the delivery
of high quality healthcare. The report of the Institute of
Medicine (IOM) ‘To Err is Human: Building a Safer
Health System’ showed that 3% to 4% of patients hospi-
talized in the United States (US) were harmed by the
care they received. The IOM concluded that poor team-
work and communication was a contributing factor in
more than one-half of medical errors [1,2]. Classen et al.
indicate that adverse events rates may be even ten times
higher than previously measured [3]. Teamwork in
healthcare is defined as a dynamic process involving two
or more health professionals with complementary back-
grounds and skills, sharing common health goals, and
exercising concerted physical and mental effort in asses-
sing, planning, or evaluating patient care [4]. In indus-
tries such as aviation and automobile manufacturing, the
value of high-performance teams has long been realized
[5]. The Agency for Healthcare and Research Quality
(AHRQ) has argued to learn from the experience in
these industries and implement various interventions
that could improve teamwork as a strategy for enhan-
cing patient safety and reducing medical errors [6]. A
meta-analysis on team-training interventions across dif-
ferent settings reported that they account for approxi-
mately 20% of the variance in team performance [7]. A
RAND report that reviewed 16 healthcare studies found
empirical evidence supporting the relationship between
teamwork and patient outcomes [8].
One of the interventions that can promote teamwork
in healthcare is the implementation of care pathways [9-
12]. Care pathways are widely used quality improvement
initiatives for organising and reorganising care processes
[13]. Compared with other care coordination interven-
tions, such as the chronic care model or integrated care,
care pathways are most effective for standardizing low
complexity and low uncertainty care processes [14]. Un-
certainty implies in the context of care coordination that
the course of disease or treatment of a particular patient
is unpredictable. The use of care pathways supports
healthcare teams in implementing evidence-based key
interventions and reduce clinical variations in everyday
practice [15]. Furthermore, they are high-performing
work systems that improve organisational performance
by strengthening relationships and coordination among
team members [10,11]. Considering different types of
team training, as defined by the AHRQ [6], we see care
pathway development as a behaviour change interven-
tion containing a mix of cross-training, self-correction,
and team-building exercises. Through care pathway de-
velopment, roles and tasks of team members are traded,
interprofessional relations are improved, feedback on
performance is provided, short- and long-term team
goals are set, evidence-based practice increases, anoverall team vision and shared mental model is built up,
and high-performance teams can be established.
Looking at most systematic reviews on pathway-
effectiveness studies, the primarily focus is on how they
affect hospital costs, patient outcomes, and length of
stay [16-18]. The way they affect teamwork is seldom
documented. This could be explained because the main
goal of care pathways is in fact to improve patient pro-
cesses and outcomes. Improved teamwork is then merely
seen as one of the important mediators and facilitators
to achieve that goal [19,20]. However, as Thomas et al.
state, quality improvement initiatives as care pathways,
although not always explicitly targeted, could actually
improve teamwork and even have better results for
patients than other team training interventions that
focus solely on teamwork [21]. A recent systematic re-
view did find a positive, but cautious, indication that a
relationship between care pathways and teamwork does
exist [12]. Although evidence was of rather low quality,
most frequently positive effects of care pathways were
found on staff knowledge, interprofessional documenta-
tion, team communication, and team relations. The re-
view also identified some negative effects of care
pathways, of which most importantly were increased
workload and emerging team conflicts through care
pathway implementation. Furthermore, as mentioned in
their commentary on the review by Salas et al., good
teamwork is not only about standardized communica-
tion protocols [22]. Attention in care pathways should
be given to create the ability to adapt, innovate, and
react efficiently and effectively when the situation calls
for it. The review concluded that the absence of high-
level evidence is due to the lack of high-quality designs
and the failure to use validated team indicators in
pathway-effectiveness studies.
The European Pathway Association (E-P-A) defines a
care pathway as ‘a complex intervention for the mutual
decision making and organisation of care for a well-
defined group of patients during a well-defined period’
[23]. As complex interventions, they are built up from a
number of components that may act both independently
and interdependently [24]. Although they are difficult to
specify, these interacting components seem essential to
the proper functioning of the intervention. The more it
is difficult to exactly define the active components of an
intervention, and how these interrelate, the more it is
likely that the intervention is a complex one [24,25].
Care pathways seem to be at the higher end of the com-
plexity spectrum. According to an international survey
on use of care pathways, possible active components are
increased evidence-based care, improved coordination of
the care process, improved communication with the pa-
tient, improved teamwork, improved follow-up and
increased efficiency [13]. Nonetheless, strong evidence
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Furthermore, knowledge on the process of pathway im-
plementation is sparse and variations in how organisa-
tions go about the implementation process are large
[19]. Multiple behavioural and organisational compo-
nents will influence the extent to which they can be suc-
cessfully integrated into everyday healthcare practice.
Evaluating and implementing care pathways therefore
requires understanding on how and in what circum-
stances they work by exploring the context in which
they are implemented and the interrelating mechanisms
that define their success [26,27].
Objectives
The primary objective of the European Quality of Care
Pathways (EQCP) study is to evaluate the impact of care
pathways on interprofessional teamwork in healthcare
teams in an acute hospital setting. A secondary goal is to
build up knowledge on the active components of care
pathways and on the conditions under which they can




The EQCP study is an international multicentre research
project launched by the European Pathway Association
(E-P-A) (http://www.E-P-A.org), an international not-
for-profit association. The E-P-A is collaborating with
the Centre for Health Services and Nursing Research of
the Faculty of Medicine of the Catholic University Leu-
ven (Belgium) and the School of Public Health of the
Amedeo Avogadro University of Eastern Piedmont
(Italy) who take the scientific lead in this study. As
explained in more detail in Vanhaecht et al. [23], the
overall project consists of three parts: a trial focusing on
the impact of a care pathway for exacerbation of chronic
obstructive pulmonary disease (COPD-exacerbation) on
patient processes and outcomes; a trial focusing on the
impact of a care pathway for proximal femur fractureFigure 1 Study design of the EQCP-trial on teamwork.(PFF) on patient processes and outcomes; and a trial we
are discussing here focusing on the impact of care path-
ways on interprofessional teamwork in which both
COPD-exacerbation and PFF-clinical teams are included.
The study is being performed in four countries: Belgium,
Ireland, Italy and Portugal. In each country, a research
centre is coordinating the project based on an inter-
national agreed protocol and a national coordinator is
appointed. Furthermore, each participating team is
asked to appoint a study coordinator as local facilitator
for the study.
Study design
To evaluate the effect of the care pathway, a stratified
post-test-only cluster randomised controlled trial (cRCT)
is used (Figure 1). In cRCTs, groups of people, rather
than individuals, are randomised into an intervention
and a control group. Because care pathways are complex
interventions and they are developed for and will affect
groups of people, a cluster randomised design is
required to evaluate their effectiveness [24,25]. Each
cluster consists of all individual members of the inter-
professional team caring for patients hospitalized for
COPD-exacerbation or PFF in a particular hospital.
Stratified randomisation was used to assign the teams to
an intervention group (using care pathways) and a con-
trol group (usual care). Interprofessional teams were
randomised. COPD/PFF was used as blocking factor. To
ensure that clusters in both arms are in balance, they are
stratified for country-level, hospital type (teaching versus
non teaching), size of hospitals (<600 and ≥600 beds),
and annual volume of patients (<300 and ≥300 patients).
Before the start of the randomisation process, random
numbers were assigned to each cluster by a researcher
not involved in the study, using the online available tool
‘Research Randomizer’ (www.randomizer.org). Next, the
researcher randomly allocated the coded clusters to the
intervention or control group using the same online
tool. Through this, the randomisation process itself was
fully concealed. Afterward, the research team and the
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were allocated just before the start of the intervention.
Each team randomised in the intervention group will
implement the complex intervention for the develop-
ment and implementation of a care pathway for COPD-
exacerbation or PFF (see in more detail below). The
teams randomised in the control group will not imple-
ment the complex intervention, and thus will provide
usual care. The intervention teams will have about nine
months to implement the complex intervention. After
this time period, a summative evaluation will be per-
formed in which performance on team indicators will
be compared between the intervention and control
group.
To enhance understanding on how the complex inter-
vention, in case the care pathway, was actually imple-
mented and under what conditions this implementation
process was successful or not, the use of qualitative
methods such as process evaluations alongside rando-
mised controlled trials is advised [28]. This is because
multiple behavioural and organisational factors will in-
fluence the extent in which the intervention can be inte-
grated into everyday healthcare practice [29]. These
factors will in turn determine their actual effectiveness.
Therefore, the context in which the care pathway was
developed and the implementation process will be evalu-
ated using process measures during and after pathway-
implementation in the intervention group.Inclusion and exclusion criteria
Inclusion on cluster level required the written agreement
to participate from the hospital management, the med-
ical head of the division, and the head nurse. In addition,
they had to agree that they will not develop and imple-
ment a care pathway for COPD-exacerbation or PFF
within the time frame of the study when randomised in
the control group. Finally, the participating hospitals
needed an expected volume of more than one hundred
COPD-exacerbation or PFF patients annually. To have aFigure 2 Participating teams in the EQCP-trial on teamwork.comparable sample across all clusters, the following in-
clusion criteria on individual level are:
1. All professionals that according to the medical head
of the division and head nurse are members of the
interprofessional team caring for COPD-
exacerbation or PFF patients from admission until
discharge out of the acute hospital ward.
2. To be part of the interprofessional care team is
further conceptualized as being part of the group of
clinicians and staff who have a shared clinical
purpose and direct care responsibilities for the
respective patient group during the set time period.
3. All individual participants need to be member of the
team during one specific week—chosen by the study
coordinator and can be defined as an average week,
with normal staff ratios—where patients are being
followed for the two other trials of the EQCP
project [23]; Because we want to study
interprofessional teamwork, each cluster is asked to
minimally include the orthopaedic surgeons/
pneumologists, head nurse, nurses, physiotherapists,
and social workers in their sample. Based on their
own judgment, the medical head of the division, in
consensus with the head nurse, can decide
to include other professional groups in
their sample.
4. In some hospitals COPD-exacerbation or PFF
patients are being admitted at multiple nursing
wards, e.g., due to capacity problems or other
organisational issues. If that is the case, then the
clusters are asked to only include these team
members that are working on the ward where the
respective patient groups are being admitted most
frequently.
Exclusion criteria are:
1. All team members that are not working (e.g., on
leave) during the chosen week.
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the team (e.g., student nurses in training).
Sample size
In each of the four participating countries, hospitals
were asked to participate by E-P-A in close cooperation
with each national coordinator. In total, 132 teams (65
COPD teams and 67 PFF teams) agreed to participate
(Figure 2). After the randomisation process, 68 teams
were assigned to the intervention group (33 COPD
teams and 35 PFF teams). Sixty-four teams were
assigned to the control group (32 COPD teams and 32
PFF teams).
Sample size calculation in a cRCT is based on the
expected improvement in the main outcome parameter
[24,30]. Our research team decided to use the team
process indicator ‘relational coordination’ as main out-
come parameter for the EQCP-trial on teamwork. The
concept of relational coordination (RC) describes a mu-
tually reinforcing process of communicating and relating
for the purpose of task integration [31]. The following
criteria justify our choice: RC describes communication
and relations within the type of teams we are focusing
on; an international panel of scientific experts and hos-
pital managers identified team communication and rela-
tions as highly relevant for follow-up as team indicators
(Content Validity Indexes of 89% and 86%, respectively)
[32], and both are dimensions measured with the con-
cept of RC; Gittell et al. showed that there is a clear me-
diating relationship between RC and the performance
effects of care pathways [10]; and systematic literature
review showed a positive relation between care pathways
and both team communication and relations [12].
To calculate the expected improvement, existing data
available through the formative evaluation (see below) of
the 20 participating Belgian clusters randomised in the
intervention arm were used. This set contains the scores
on RC of 362 participating individual team members.
RC is scored on a scale from 1 (low RC) to 5 (high RC).
The range of the average RC-scores on cluster level inFigure 3 Active components of the EQCP-complex intervention.the dataset was 2.9 to 3.9. The gap between the highest
and lowest score was thus 1.34. We then identified 4 as
cut-off score, because this is the average between our
top score (3.9) and the top score (4.2) in the nine-
hospital study of Gittell et al. [31]. In our sample, 30%
of participants (107/362) scored higher than 4. If we take
this actual gap as expected improvement, then we can
expect that the percentage of participants scoring more
than 4 would increase to 40% after care pathway imple-
mentation (30%*1.34). Based on a power of 80% and a
significance level of 0.05 (two-sized), we would need up
to 364 team members per arm to observe a difference of
10% (case = 40%; control = 30%) in number of partici-
pants scoring higher than 4 on RC. Given an inflation
factor (IFF = 1.306) using the ICC out of two previous
cRCTs on pathway-effectiveness by Panella et al. (ICC=
0.018) and the average sample size of the Belgian clus-
ters in the intervention group during the formative
evaluation (n = 17) [33,34], the required sample size
increased to 475 team members per arm. Considering
the average sample size of 17 team members per cluster,
we need 28 clusters per arm.
The complex intervention: care pathway implementation
in the intervention arm
The care pathway intervention contains three active
components (Figure 3):
1. Formative evaluation of the teams’ performance
before implementation: For this, a measure of the
teams’ performance on team indicators and on
patient process indicators is planned. The set of
team indicators that will be used for this evaluation
is described below. The patient process indicators
are described in the research protocols of the other
two EQCP trials [35,36]. These process indicators
measure the teams’ compliance to the key
interventions in the care process. Key interventions
are those that, based on evidence-based medicine,
need to be performed to guarantee high-quality care,
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outcomes. An evaluation of performance to these
process indicators will be performed for 20
consecutive patients. Each team will receive a
feedback report with their own results, both on
team and on patient level, benchmarked with the
results of the other participating teams.
Furthermore, a workshop per country will be
organised on the interpretation of these results and
on how these results should be presented to the
teams. These workshops will be lead by an
organizational psychologist (M.E.) and experts in
care pathway development (K.V. and W.S.). All
involved study coordinators will be invited. After a
general introduction, the participants will be divided
in small groups of five to help them interpret the
results. The formative evaluation will help the teams
to understand their actual performance, their points
for improvement, and their actual level of
organisation of the care process.
2. Evidence-based key interventions: Each team will
receive a set of evidence-based key interventions for
COPD-exacerbation or PFF. This set is based on an
extensive literature review, Map of MedicineW
(http://www.mapofmedicine.com), and on consensus
by international clinical experts using a Delphi
survey. The key interventions and outcomes include
both in-hospital interventions and information for a
safe discharge. A workshop will be organised on the
content and evidence base of these interventions.
These workshops will be lead by clinical experts in
COPD and PFF. Next to the study coordinator, three
key stakeholders of the participating teams will beFigure 4 Care pathway implementation protocol based on the Demininvited. A teach-the-teacher based approach
will be used.
3. Training in pathway development: Each study
coordinator will be trained to develop the care
pathway based on the findings of the formative
evaluation. In the training workshop, a care pathway
implementation protocol based on the Deming Plan-
Do-Study-Act cycle and behavioural change
strategies, which is generally accepted as the
standard method for care pathway implementation,
will be used (Figure 4) [37]. These one-day
workshops will be led by experts in pathway
development (W.S. and K.V.) and organizational and
team change (M.E.). Again, a teach-the-teacher
based approach will be used. Change will be further
supported by giving the possibility to exchange best
experiences among participating teams.
Measures
The set of effect measures is described in Table 1. Team-
work is traditionally described using systems theory with
an ‘input-process-output’ based approach [6]. This im-
plies that effectiveness of teamwork is defined by a com-
plex set of interactions between team inputs (context
and structure of the team), team processes, and team
outputs. Because we want to study the impact of care
pathways on all facets of teamwork, we adopted this
multifaceted ‘input-process-output’ approach in our
choice of team indicators. The selection of measures is
based on the international expert panel on relevant indi-
cators to follow-up in care processes [32] and the sys-
tematic review of the relationship between care
pathways and teamwork [12]. Hence, the research teamg-PlanDoStudyAct cycle.
Table 1 Set of effect measures
Effect measures Typology Level of analysis Description Instrument Respondents
Team composition Team input Cluster level The different professional groups of which the team is built up of. Team membership list Study coordinator
Team reflexivity Team input Cluster level Frequency of follow up of the care process. Structured questionnaire Study coordinator
Team meetings Team input Cluster level Frequency of team meetings. Structured questionnaire Study coordinator
Number of different professional groups attending team meetings.
Leadership structure Team input Cluster level Leadership structure of the team: No team leader/1 team leader/
shared leadership
Structured questionnaire Study coordinator
Coordinating mechanisms Team input Cluster level Use of guidelines and protocols, information systems, case management,
interdisciplinary patient rounds, and interdisciplinary team meetings.
Structured questionnaire Study coordinator
Dedicated team members Team input Individual level If team members are exclusively dedicated to COPD of PFF
care within the team or not.
Structured questionnaire Team members
Perceived ‘teamness’ Team input Individual level To what extent is the team perceived by the team members as being
a real interprofessional team?
Structured questionnaire (score 1–5) Team members
Work environment Team input Individual level To what extent is the work environment supportive for teamwork? Structured questionnaire (score 1–5) Team members
Management support Team input Individual level To what extent is the hospital management supportive for teamwork? Structured questionnaire (score 1–5) Team members
Conflict management Team process Individual level The quality of how conflicts are managed within the team. Structured questionnaire (score 1–5) Team members
Leadership quality Team process Individual level Quality of leadership: general satisfaction with leader, leadership
skills and effectiveness of leadership.
Structured questionnaire (score 1–5) Team members
Team involvement Team process Individual level How involved does each team member feel with the team? Structured questionnaire (score 1–5) Team members
Team climate for innovation Team process Individual level - Team Vision: clarity of and commitment to objectives (4 items) Team Climate Inventory[38] Team members
- Participative safety (4 items)
- Task orientation: emphasis on quality (3 items)
- Support for innovation (3 items)
Relational coordination Team process Individual level - Communication dimensions (4 items): frequent, timely, accurate
and problem solving communication
Relational Coordination Survey[31] Team members
- Relationship dimensions (3 items): shared goals, shared knowledge
and mutual respect
Level of organised care Team output Individual level Level of organisation of the care process: Care Process Self Evaluation Tool[39] Team members
- Patient focused organisation (6 items)
- Coordination of CP (7 items)
- Communication with patient and family (4 items)
- Collaboration with primary care (3 items)
- Follow up of CP (9 items)
Work Engagement Team output Individual level Level of engagement to work: Burn Out Inventory[40] Team members
- Emotional exhaustion (5 items)
- Mental detachment (5 items)
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both on identified relevance to follow-up and expected
effect of care pathways. As mentioned before, relational
coordination is our primary effect measure. Next to the
effect measures, a set of covariates will also be measured
(Table 2). All team indicators will be analyzed on indi-
vidual level, except for some team input indicators that
will be measured on cluster level. These data will be col-
lected with the use of both validated tools and struc-
tured questionnaires developed by the research team.
The study coordinators will be trained in how all tools
need to be completed. To guarantee anonymity, the
team members will be asked to return the completed
surveys to the study coordinators in a closed envelope.
Afterward, these closed envelopes will be collected by a
member of the research team.
The process measures that will be used in the interven-
tion group are described in Table 3. First, to measure the
level of adherence to the complex intervention, the study
coordinator will have to score to what extent the evidence-
based key interventions were actually implemented. Sec-
ond, to evaluate the implementation process, process
follow-up files will be administered to the study coordina-
tors at several time points during and after implementa-
tion. Furthermore, semi-structured interviews with key
stakeholders of each cluster will be performed after imple-
mentation. We are planning to interview representatives of
three groups of stakeholders: the study coordinator, hos-
pital management, and key stakeholders of the interprofes-
sional team. For each of these groups, a specific interview
guide will be developed. Considering the largeTable 2 Set of covariates
Covariates Level of analysis Description
Randomisation group Cluster level Group in which the team
Patient group Cluster level Patient group for which
is being developed.
Team size Cluster level Number of individuals in
Hospital characteristics Cluster level - Number of beds
- Patient volume
- Teaching status
- Dedicated ward or not
Team tenure Cluster level Average number of years
members are part of the
Individual characteristics
of the team member
Individual level - Age and gender
- Professional group of te
- % of working time
- Years of experience wit
- Years of being a team m
- Has the team member
the teaminternational sample, to enhance feasibility, the interviews
will only be performed in a selection of clusters.
Statistical analysis
To analyze results, multilevel analysis will be performed.
Common descriptive statistics (Fisher exact and Kruskal
Wallis test for categorical and continuous variables, re-
spectively) will be performed on the cluster level. The
differences in the effect measures will be evaluated on
team or individual level using respectively random-
effects logistic or linear regression models, and account-
ing for the clustering effect. Statistical significance will
be defined as a two-sided p-value <0.05. All analyses will
be carried out using SAS 9.2 statistical software.
Registration and ethical approval
The ethical approval is obtained on three levels: ethical
approval by the ethical committee (EC) of the coordinat-
ing centre on country level: the EC of the University
Hospitals of Leuven for Belgium (identifiers:
B32220096036 and B32330096038), the EC of the Na-
tional Committee of Data Protection for Portugal (iden-
tifiers: 6605/2011 and 6497/2011), the EC of AOU
Maggiore della Carità di Novara for Italy (identifier: 625,
21/07/2011), and the EC of Mid-Western Regional Hos-
pital, Limerick for Ireland; ethical approval with regard
to the participation in the study is provided on cluster
level, namely by the EC of each of the hospitals of the
participating teams; and individual informed consent is
sought from the team member with regard to the par-
ticipation in surveys.Instrument Respondents
was randomised. Structured questionnaire Study coordinator
the care pathway Structured questionnaire Study coordinator
the team. Team membership list Study coordinator
Structured questionnaire Study coordinator
that the team
team.
Structured questionnaire Team members
Structured questionnaire Team members
am member
h the patient group
ember
a leading role within
Table 3 Set of process measures
Process measures Typology Description Instrument Respondents
Adherence to the complex
intervention
Implementation parameter Process adherence parameter measuring the extent to which the
evidence-based key interventions were actually implemented.
Process-follow-up files Study coordinator
Project team composition Implementation parameter The composition of the project team:
size and professional groups that are part of it.
Process-follow-up files Study coordinator
Project satisfaction Implementation parameter Satisfaction with the implementation process. Process-follow-up files Study coordinator
Project meetings Implementation parameter Number of meetings the project team
organised during the implementation process.
Process-follow-up files Study coordinator
Facilitators and barriers Implementation parameter What facilitators and barriers were encountered
during the implementation process of the care pathway?
Semi-structured interviews Study coordinator and stakeholders
of the management and team
Pathway effectiveness Implementation parameter How did the implementation of the care pathway
affect patient care and teamwork?
Semi-structured interviews Study coordinator and stakeholders
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The EQCP study on teamwork is the first cRCT on the
impact of care pathway implementation on interprofes-
sional teamwork. As the World Health Organisation
(WHO) World Alliance for Patient Safety points out,
improving communication and coordination has to be
priority number one for patient safety research and prac-
tice in developed countries [41]. Furthermore, team-
directed implementation strategies for change in health-
care are still seldom studied [42]. Following Thomas
et al., we believe that care pathways, as being interpro-
fessional quality improvement initiatives, can improve
teamwork and install high-performing teams [21].
Through their use, care processes are organised, roles
and tasks are standardized, clear team goals are set, and
a team vision is built. This will lead to improved team
communication and will install high quality interprofes-
sional relations, which could in turn improve teamwork
in all its facets.
Quality improvement initiatives as care pathways are
strongly linked with behavioural change. Looking at the
Theory of Planned Behaviour, effective behavioural change
is guided by three kinds of considerations: normative, be-
havioural, and control beliefs [43]. With our complex inter-
vention, containing three active building blocks, we expect
to affect all three defining factors. The feedback on the ac-
tual performance should create normative beliefs and mo-
tivation for change. The set of evidence-based key
interventions should create behavioural beliefs that comply
with these interventions will actually improve patient out-
comes and thus team performance. Finally, the training in
care pathway development should install beliefs of control
over factors that can facilitate or impede pathway imple-
mentation. Therefore, we are confident that with these
three components, the teams will have the necessary tools
to implement real change.
One strength of the study is the use of a high-quality
cRCT design with multilevel analysis, as required to
evaluate complex interventions affecting groups of
people [24]. Second, we include in our design a realistic
evaluation approach by using process evaluations [28].
Third, we study the impact on teamwork in all its facets,
using an input-process-output approach. Fourth, the
choice of team indicators to follow-up is based on exten-
sive literature review and international expert panel.
Fifth, we set clear inclusion criteria for team members,
which will enhance the comparability of our clusters. On
the contrary, we did give the medical head of the div-
ision and head nurse the opportunity to choose add-
itional professional groups that are also members of
their team according to them, because ‘team compos-
ition’ is one of our team input indicators. Because we ex-
pect that the intervention teams will evaluate the
composition of their team, our hypothesis is that theywill be composed of more professional groups than
the control teams. Sixth, the international nature of
the study, and because we both include COPD teams
(medicine) as PFF teams (surgery), increases generalis-
ability. Finally, with the large number of participating
teams, we should have enough power to find signifi-
cant effects.
A challenge for the study is that, although our complex
intervention with its three building blocks is standar-
dized, this does not imply that the implementation
process will be fully under control. This is a key feature
of complex interventions. The teams will have the ability
to choose which key interventions they want to include
or exclude. Organisational context and team conditions
will influence the implementation process, and thus will
have an impact on pathway-effectiveness [44]. Nonethe-
less, the implementation processes will be strictly
followed-up using the Normalisation Process Model that
will enable us to define active components and preferred
implementation strategies [29]. Second, because teams
involved in pathway development frequently are newly
formed work groups and comprise different professionals
with different professional backgrounds and cultures,
these teams will have to struggle through the initial for-
mative stages of group development [45]. Professional
fragmentation and emerging team conflicts could there-
fore influence each professions’ response to the imple-
mentation of care pathways [46]. These specific
conditions could thus influence our study results. Third,
because care pathways are primarily used to improve pa-
tient processes, the focus during pathway development
could center solely on compliance to the key interven-
tions in the process and not on improving teamwork
[21]. Fourth, because this is the first controlled trial that
will study the impact of care pathways on relational co-
ordination, no data out of literature were available to de-
fine the expected improvement. This increases
uncertainty about our sample calculation. Fifth, non-
response to surveys could influence the results. Sixth,
results will be primarily based on self-reported measures,
causing some limitations such as possible social desirabil-
ity bias. Finally, the summative evaluation will occur at
one time point only. Therefore, we will not be able to
measure the sustainability of the effect of care pathways.
Results from our study will allow researchers and
healthcare managers to draw conclusions on the interre-
lations and interactions between care pathway imple-
mentation and team inputs, processes, and outcomes.
Through this, body of knowledge on the active compo-
nents and facilitators of care pathway implementation
will be further developed, and preferred implementation
strategies can be defined. This should guide healthcare
teams in actively improving the quality and safety of care
processes.
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